Katherine Skillman
Payments from drug & device makers
Across 82 payments — averaging $15.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$183
- Lilly USA, LLC$150
- GSK$109
- Abbott$92
- Novo Nordisk$84
- Boehringer Ingelheim$81
- plus $570 from 22 others
What the payments were for
- Food & beverage$1,269100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 12 | $183 |
| Lilly USA, LLC | 9 | $150 |
| GSK | 8 | $109 |
| Abbott | 4 | $92 |
| Novo Nordisk | 6 | $84 |
| Boehringer Ingelheim | 5 | $81 |
| Pfizer | 5 | $68 |
| Astellas Pharma US Inc | 4 | $54 |
| Merck | 3 | $47 |
| Biohaven Pharmaceuticals, Inc. | 2 | $41 |
| AbbVie | 2 | $31 |
| Novartis | 2 | $30 |
| Xeris Pharmaceuticals, Inc. | 2 | $30 |
| AstraZeneca | 2 | $28 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $26 |
| Tonix Medicines, Inc. | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Mylan Specialty L.p. | 1 | $20 |
| Medtronic | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| Hologic Sales And Service, LLC | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Eisai Inc. | 1 | $13 |
| Ironwood Pharmaceuticals, Inc | 1 | $12 |
| Genentech USA, Inc. | 2 | $5 |
How this compares
$1,269 in reported general payments places this provider in the 65th percentile of 878 medical providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 76 | $89,916 |
| JardianceEmpagliflozin | 89 | $82,255 |
| MounjaroTirzepatide | 51 | $57,257 |
| EliquisApixaban | 46 | $31,187 |
| TrulicityDulaglutide | 19 | $23,890 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 38 | $23,890 |
| LialdaMesalamine | 14 | $17,933 |
| Nurtec OdtRimegepant Sulfate | 18 | $17,812 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 12 | $9,416 |
| JanuviaSitagliptin Phosphate | 13 | $7,326 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 21 | $6,442 |
| Spiriva RespimatTiotropium Bromide | 11 | $5,504 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 31 | $3,357 |
| Duloxetine Hcl | 153 | $3,255 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 92 | $3,049 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $84 | $89,91676 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $81 | $87,759100 claims |
| Lilly USA, LLCMounjaro, Trulicity | $150 | $81,14770 claims |
| PfizerEliquis, Nurtec Odt | $68 | $49,00064 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $109 | $33,30550 claims |
| MerckJanuvia | $47 | $7,32613 claims |
| AbbVieSynthroid | $31 | $80117 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 878 medical providers in North Carolina.
Other medical in Eden
- Donna JenningsEden$11K
- Grace McLaurinHickory$553K
- Joel ThompsonCharlotte$269K
- Virginia JethroCary$213K
- Payal Soni-PatelAsheville$76K
- William JarrettElkin$59K
- Amanda ZimmermanWinston Salem$48K
- David TaylorMorehead City$40K
- Katherine CardSalisbury$39K
- John RobbinsWinston Salem$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.